Low dimensionality of phenotypic space as an emergent property of coordinated teams in biological regulatory networks

Biological networks driving cell-fate decisions involve complex interactions, but they often give rise to only a few phenotypes, thus exhibiting low-dimensional dynamics. The network design principles that govern such cell-fate canalization remain unclear. Here, we investigate networks across diverse biological contexts– Epithelial-Mesenchymal Transition, Small Cell Lung Cancer, and Gonadal cell-fate determination – to reveal that the presence of two mutually antagonistic, well-coordinated teams of nodes leads to low-dimensional phenotypic space such that the first principal component (PC1) axis can capture most of the variance. Further analysis of artificial team-based networks and random counterparts of biological networks reveals that the principal component decomposition is determined by the team strength within these networks, demonstrating how the underlying network structure governs PC1 variance. The presence of low dimensionality in corresponding transcriptomic data confirms the applicability of our observations. We propose that team-based topology in biological networks are critical for generating a cell-fate canalization landscape.

[1]  D. Kessler,et al.  Minimal frustration underlies the usefulness of incomplete regulatory network models in biology , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Onuchic,et al.  Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer , 2022, bioRxiv.

[3]  V. Rajapakse,et al.  Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models , 2022, Nature Communications.

[4]  M. Jolly,et al.  Emergence of hybrid states of stem-like cancer cells correlates with poor prognosis in oral cancer , 2022, iScience.

[5]  S. Quake The Tabula Sapiens: a multiple organ single cell transcriptomic atlas of humans , 2021, bioRxiv.

[6]  M. Jolly,et al.  Landscape of epithelial–mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks , 2021, bioRxiv.

[7]  M. Jolly,et al.  Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes , 2021, Physical biology.

[8]  M. Jolly,et al.  A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells , 2021, bioRxiv.

[9]  M. Jolly,et al.  Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma , 2021, bioRxiv.

[10]  M. Jolly,et al.  Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer , 2020, bioRxiv.

[11]  M. Jolly,et al.  Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology , 2020, bioRxiv.

[12]  C. Kadelka,et al.  A meta-analysis of Boolean network models reveals design principles of gene regulatory networks , 2020, Science advances.

[13]  Atchuta Srinivas Duddu,et al.  Multi-stability in cellular differentiation enabled by a network of three mutually repressing master regulators , 2020, Journal of the Royal Society Interface.

[14]  Shubham Tripathi,et al.  Biological Networks Regulating Cell Fate Choice Are Minimally Frustrated. , 2020, Physical review letters.

[15]  K. Dill,et al.  How Do Cells Adapt? Stories Told in Landscapes. , 2020, Annual review of chemical and biomolecular engineering.

[16]  M. Jolly,et al.  Cancer Stem Cell Plasticity – A Deadly Deal , 2019, Frontiers in Molecular Biosciences.

[17]  Shivashankar H. Nagaraj,et al.  Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer , 2019, Journal of clinical medicine.

[18]  Aaron M. Newman,et al.  Single-cell transcriptional diversity is a hallmark of developmental potential , 2019, Science.

[19]  J. Onuchic,et al.  Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways , 2019, Proceedings of the National Academy of Sciences.

[20]  S. Hanash,et al.  Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas , 2019, Pharmacology & therapeutics.

[21]  E. Furth,et al.  EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. , 2018, Developmental cell.

[22]  S. Zapperi,et al.  Topography of epithelial–mesenchymal plasticity , 2018, Proceedings of the National Academy of Sciences.

[23]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[24]  H. Levine,et al.  EMT and MET: necessary or permissive for metastasis? , 2017, bioRxiv.

[25]  Bin Huang,et al.  Interrogating the topological robustness of gene regulatory circuits by randomization , 2016, bioRxiv.

[26]  I. Mackenzie,et al.  Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma , 2016, EBioMedicine.

[27]  Reka Albert,et al.  Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypes , 2015, npj Systems Biology and Applications.

[28]  Luis Mendoza,et al.  A Boolean network model of human gonadal sex determination , 2015, Theoretical Biology and Medical Modelling.

[29]  Catherine Ha Ta,et al.  An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States , 2015, PLoS Comput. Biol..

[30]  Z. Bao,et al.  The Regulatory Landscape of Lineage Differentiation in a Metazoan Embryo. , 2015, Developmental cell.

[31]  Eshel Ben-Jacob,et al.  MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.

[32]  Richard C. McEachin,et al.  Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer , 2013, PloS one.

[33]  E. Levanon,et al.  Human housekeeping genes, revisited. , 2013, Trends in genetics : TIG.

[34]  Jianhua Xing,et al.  Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition. , 2013, Biophysical journal.

[35]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[36]  Rui Chang,et al.  Systematic Search for Recipes to Generate Induced Pluripotent Stem Cells , 2011, PLoS Comput. Biol..

[37]  Sui Huang,et al.  Understanding gene circuits at cell-fate branch points for rational cell reprogramming. , 2011, Trends in genetics : TIG.

[38]  T. Enver,et al.  Forcing cells to change lineages , 2009, Nature.

[39]  Griffin M. Weber,et al.  BioNumbers—the database of key numbers in molecular and cell biology , 2009, Nucleic Acids Res..

[40]  B. Hall,et al.  Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest , 2006, Biological reviews of the Cambridge Philosophical Society.

[41]  David J. Wooten,et al.  Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. , 2017, Cancer research.